Consistent with this view, Mencarelli et al. reported that acute TNBS colitis causes a robust decrease in the expression of several nuclear receptors including PPAR-γ, PXR, and FXR, and that these changes were antagonized by VSL#3 cotreatment [24]. The gene discussed is NR1I2; the disease is colitis.